González Rivero M A, Mulet J F, Martín J C, Illa J, Melo M, Pardo N, Turmo J, Vela E, Badía R M, Cubells J
Cir Pediatr. 1989 Oct;2(4):186-90.
We present the result obtained by GICOP in the treatment of 12 genitourinary rhabdomyosarcoma, located in vagina-uterus (5), bladder-prostate (4) and paratesticular (3). The age of the patients ranging from 1 to 15 years. Embryonal rhabdomyosarcoma was the most common histologic type (58 for 100) being the major number of cases in stadium II. The treatment was based in the combination of chemotherapy protocolised with vincristine, d-actinomycin, cyclophosphamide (VAC), vincristine, adriamycin (VAC-VAD) and/or iphosphamide, vincristine, d-actinomycin (IVA), use of radiotherapy, marrow auto-transplantation and radical surgery avoidance. Complete remission was achieved in 11 out of 12 cases (92 for 100), relapsing in 5 cases (38 for 100) of which 4 (80 for 100) achieved a second remission. An 82 for 100 disease free survival was achieved in a 5 year period.
我们展示了GICOP在治疗12例泌尿生殖系统横纹肌肉瘤中的结果,这些肿瘤位于阴道-子宫(5例)、膀胱-前列腺(4例)和睾丸旁(3例)。患者年龄在1至15岁之间。胚胎型横纹肌肉瘤是最常见的组织学类型(占100例中的58例),在II期病例中占主要数量。治疗基于联合使用长春新碱、放线菌素D、环磷酰胺(VAC)、长春新碱、阿霉素(VAC-VAD)和/或异环磷酰胺、长春新碱、放线菌素D(IVA)的标准化化疗方案,使用放疗、骨髓自体移植并避免根治性手术。12例中有11例(占100例中的92例)实现了完全缓解,5例(占100例中的38例)复发,其中4例(占100例中的80例)实现了第二次缓解。在5年期间实现了82%的无病生存率。